THE EVOLVING THREAT OF ANTITRUST LITIGATION IN HEALTH CARE
|
|
- Oliver Turner
- 8 years ago
- Views:
Transcription
1 THE EVOLVING THREAT OF ANTITRUST LITIGATION IN HEALTH CARE WHY PROVIDERS MUST TAKE HEED By Keith Lavigne and Scott Williams
2 THE EVOLVING THREAT OF ANTITRUST LITIGATION IN HEALTH CARE In the business of medicine, health care providers must cope with the ever increasing cost of doing business and mounting competition while also facing shrinking reimbursement rates. To counter this trend, providers of all types began searching for a solution to achieve the goals of the Patient Protection and Affordable Care Act (PPACA) - increased affordability, better quality of care and access to a wider range of health services. On the heels of the PPACA, the age of bigger is better was born. Across the country, health care providers have acquired, merged or created various types of affiliations with other health care providers to fill in gaps in services, achieve greater economies of scale and deliver higher quality patient care at a lower cost. In 2014, for the third consecutive year, at least 95 transactions involving hospitals were announced which constitutes a 44 percent increase over the number of transactions announced in 2010, the year the PPACA was enacted. 1 The chief downside to these unique alignments and large number of transactions is the antitrust risk market changes born from regulation will inevitably invite additional regulation and oversight. While price-fixing and conspiracy to allocate markets remain staples of antitrust litigation, we have entered a new age of antitrust liability for health care providers. Investigations, challenges and lawsuits have targeted numerous types of business activities, but the growing edge for antitrust is undeniably related to health care Mergers and Acquisition (M&A) activity. Providers must embrace the reality that M&A activity no matter how big or small carries antitrust risk if it leads to the exercise of market power in the form of higher prices or reduced quality of care or access. Health care market participants should not expect an abatement of the vigorous antitrust enforcement. Therefore, unlike any other time in history, an unprecedented level of due diligence in M&A activities must be performed in order to avoid the severe consequences associated with antitrust liability. A New Antitrust Landscape Emerges In 2004, the Federal Trade Commission (FTC) retrospectively challenged the acquisition of Highland Park Hospital by Evanston Northwest Health Care four years earlier. The litigation in the case continues more than 14 years after its inception. So much time has passed that Evanston Northwest has since changed its name to NorthShore University HealthSystem. In the case, the FTC produced evidence that prices at the merged hospitals had increased post-transaction. The respondents argued that the merger had resulted in improved clinical quality, which justified the price increases. The Administrative Law Judge in the litigation ruled against the respondents claims, finding no evidence in the improvement of quality of care relative to other In 2014, for the third consecutive year, at least 95 transactions involving hospitals were announced which constitutes a 44 percent increase over the number of transactions announced in 2010, the year the PPACA was enacted. 1 Hospital Transactions: Source: Kaufman, Hall & Associates, LLC
3 THE EVOLVING THREAT OF ANTITRUST LITIGATION IN HEALTH CARE health care providers. In the ruling, the judge took into account a variety of inpatient outcomes, such as risk-adjusted data on inpatient mortality rates across different medical conditions and surgical procedures. The case is particularly instructive for future antitrust litigation arguing similar price-versus-quality issues. In commenting on the case, FTC Commissioner Julie Brill stated, If a merger among (health care) providers that are close substitutes increases the merged provider s leverage with health plans because of inadequate alternatives, the provider gains the ability to obtain supra-competitive pricing. 2 Even though the value of many transactions involving physician practice groups is likely to be short of the new threshold, thorough due diligence must be performed. The risk of actions by competitors seeking to enjoin these types of transactions remains significant because of the perceived increase in market power. Unless the merger produces actual cost savings, it is likely to come under the FTC s close scrutiny and spring a possible investigation. An analysis of the 2004 ruling co-authored by the FTC s Bureau of Economics confirms this view. 3 Hospital mergers are unlikely to improve quality absent a reduction in the cost of producing (this) quality, the Bureau s authors stated. In other words, hospitals contemplating a merger or acquisition should focus on the ways the alignment will reduce costs, whether by means of a superior hospital exporting its knowledge and practices to an inferior one, through economies of scale, or as a result of differences in financial resources, the authors wrote. 4 If higher prices cannot be justified by demonstrable improvements in quality care, the parties involved may be retrospectively subjected to unwinding a multi-yearold transaction. After a string of government defeats to similar cases in the 1990 s, this case has since become the foundation of subsequent government investigations and antitrust litigation involving the health care industry. As Commissioner Brill boasted in June 2014, Using the improved enforcement framework beginning with our Evanston case, we now have an impressive string of victories under our belt. 5 Developing Legal Threats As providers continue to pursue M&A deals, they must give more consideration to evolving federal antitrust and private litigation actions. For example, the revised reporting threshold under the Hart-Scott-Rodino (HSR) Antitrust Act opens up industry M&A transactions to greater regulatory scrutiny. The HSR Act requires that the parties engaging in a proposed M&A transaction file notifications with the FTC and Department of Justice (DOJ) when the transaction exceeds a specified threshold. The 2015 revised threshold under HSR automatically triggers notification when the transaction value exceeds $76.3 million, up from $75.9 million in When notification is required, the transaction cannot close until the regulators approve the deal. Take, for instance, Idaho-based St. Luke s Health System s acquisition of Saltzer Medical Group, a large independent, multi-specialty physician practice group also located in Idaho. The case is the first fully litigated challenge by the FTC to a hospital s acquisition of a physician practice. The complaint alleged that the acquisition had combined the two largest providers of adult primary care physician services in the Nampa, Idaho area, with the intent of increasing St. Luke s ability and incentive to demand higher reimbursement rates from commercial health plans, thereby leading to higher health care costs for Idaho employers and area consumers. The St. Luke s Saltzer Medical merger was not subject to the HSR notification requirements, as the value of the deal fell below the threshold. The transaction closed in late 2012, after the court denied a preliminary injunction motion filed by St. Luke s competitors, St. Alphonsus Health System and Treasure Valley Hospital, to stop the acquisition. The FTC subsequently joined the fight in 2013, and filed an action in federal district court to block the deal. In early 2014, the trial court and the United States Court of Appeals for the Ninth Circuit ruled that the transaction violated both the state s anti-competition rules and Section 7 of the federal Clayton Act. Although the judge in the case, Chief Judge Lynn Winmill of the U.S. District Court for the District of Idaho, initially applauded St. Luke s for its foresight and vision in trying to improve health care delivery through the acquisition, he ultimately found no convincing proof of extraordinary efficiencies ample enough to overcome the higher prices. 7
4 THE EVOLVING THREAT OF ANTITRUST LITIGATION IN HEALTH CARE The risk of actions by competitors seeking to enjoin these types of transactions remains significant because of the perceived increase in market power. Judge Winmill further attested that there are other ways to achieve the same [health care quality improvements] that do not run afoul of the antitrust laws and do not run such a risk of increased costs. 8 The ruling is the first time a federal court has found a hospital s purchase of a physician practice to be unlawful. Following the court s decision, FTC Chairwoman Edith Ramirez issued a statement applauding the decision as an important victory for both competition and consumers. 9 The hospital will have to fully divest itself of Saltzer Medical s assets and physicians. Obviously, the financial costs of pursuing the transaction, closing the deal, attending to preliminary post-merger integration needs, and then unwinding the merged entity were not insignificant for either party. Heightened Enforcement As these cases signify, the FTC and DOJ are devoting substantial resources to litigating M&A transactions in the health care sector. Since President Obama took office, the percentage of formal requests by the agencies for socalled second requests a signal that the agencies will undertake an investigation of a transaction has increased by approximately 40 percent. 10 In the aftermath of the stepped-up investigations by the DOJ and FTC, numerous law firms have issued timely notices to clients to prepare for possible antitrust litigation, noting that if the transaction appears to alter the health care industry s competitive landscape, it will surely arouse suspicion. Since virtually every transaction has the potential of shifting the competitive balance, all M&A activity is likely to be scrutinized. The St. Luke s-saltzer Medical case underlines the perceived conflict that exists between the FTC s antitrust regulations and a hospital s need to provide more efficient health care under the PPACA. Although the Administrative Judge in the case agreed with the transacting hospitals that the primary purpose of the acquisition was to improve patient outcomes via a more integrated medical system, the post-transaction efficiencies were found not to be merger-specific, i.e., other ways existed to achieve the same objectives. 11 The objective of greater accessibility to health care services under the PPACA and the enforcement obligations of the FTC appear to be in conflict. The industry is thus confronted with a confounding paradox: while the PPACA is compelling sector consolidation to increase provider scope and scale, government antitrust investigations are aimed at limiting this activity. The FTC is dismissive of this assertion. The agency s position is that higher quality of care and antitrust investigations have the common goal of promoting highquality and cost-effective health care. 12 Some providers [are] complaining that the federal government is `speaking out of both sides of its mouth, with the Medicare program encouraging providers to come together and create organizations that will enable greater collaboration, while the antitrust agencies challenge them, Commissioner Brill stated. 13 But, as she further commented, numerous studies have found that the existence of excess provider market power results in higher prices, lower quality, and less innovation. More Threats Ahead The potential unwinding of the St. Luke s-saltzer merger is sure to test the boundaries of legal coordination of health care integration under the federal antitrust laws. If the past is any indication of the future, the health care industry can expect an increase in similar government investigation and enforcement actions. Certainly, the FTC has made it abundantly clear that it has no intention of weakening its resolve to pursue and punish anticompetitive behavior. Sometimes we are told that antitrust has no role in rapidly evolving industries (like the health care sector), but we disagree, stated Deborah Feinstein, director of the FTC s Bureau of Competition, in a June 2014 speech. Effective antitrust enforcement is as important in a time of dynamic change as in periods of stability, if not more so. 14
5 THE EVOLVING THREAT OF ANTITRUST LITIGATION IN HEALTH CARE The health care sector can expect no empathy from the FTC for the profound impact of the PPACA on the industry. As Ms. Feinstein explained, the FTC is a law enforcement agency, and not a regulatory body. We take what is before us and decide whether it violates the antitrust laws, she said, adding that a competitive health care marketplace (is) crucial to the success of on-going health care reform efforts. Due Diligence Dimensions The bottom line is that the FTC will continue to aggressively target M&A transactions in the health care sector if it appears this activity has harmful effects on pricing and competition, whether the transaction has been finalized or not. In this environment, hospitals must contemplate several key threshold questions, among them: Will the proposed transaction offer the potential for pro-consumer cost savings or extraordinary quality improvements in the provision of health care services? Does the transaction constitute a bona fide integration, or is it simply a mechanism to enhance leverage with payers via joint negotiations? In developing the answers to the questions and navigating the minefield of exposures, it is imperative that health care providers work closely with legal counsel, particularly those specializing in antitrust litigation. Since all M&A activities will inevitably alter the competitive landscape in a geographic region, a comprehensive antitrust risk analysis must be part of the due diligence process. Facing The Challenges Today In light of these recent developments, health care providers must exercise greater due diligence in their pursuit of greater economies of scale. Whether through mergers, acquisitions or other forms of affiliations, heightened vigilance in managing their transactional exposures is a necessity, not an option, and failure to do so could expose these health care providers to significant risk. Stay tuned for the fourth segment of our Rising Tide of Risk for the Health Care Industry series, where we will provide an in-depth look at peer review and credentialing-related litigation, and how it can impact various issues ranging from operations to acquisitions. If the transaction is deemed to be a bona fide integration, are pricing agreements among the participants necessary to achieve the benefits of the collaboration? What impact will the proposed transaction have on the hospital s market share and the specialty services provided in its market? Are there any exclusive agreements in place with physicians in the organization and the target organization? Is there any anticipated increase in fee for service pricing structures? Should there be reason to anticipate adverse public reactions to the transaction?
6 About the Authors: Keith Lavigne is Executive Vice President, ACE USA Professional Risk, based in New York. He oversees the retail and wholesale management liability business for North America, focusing on private and not-forprofit companies. Mr. Lavigne can be contacted at Scott Williams is Vice President, ACE USA Professional Risk, based in New York. He is responsible for overseeing the underwriting operations for all private/ not-for-profit management liability accounts generated out of the New York, Boston and Atlanta regions. He previously served as Division Counsel for ACE s retail and wholesale management liability business in both the US and Canada, focusing on private and not-for-profit companies. Mr. Williams can be contacted at Scott.Williams@acegroup.com. Endnotes 1 PRWeb. Number of Hospital Transactions Remains High in 2014 According to Kaufman Hall Analysis. PRWeb.com (2015). 2 Brill, Julie. (2014). Competition in Health Care Markets. Washington, D.C.: Hal White Antitrust Conference. 3 Ibid 4 Ibid 5 Ibid 6 Federal Trade Commission. (2015). FTC Announces New Thresholds for Clayton Act Antitrust Reviews for 2015 [Press release]. Retrieved from ftc-announces-new-thresholds-clayton-act-antitrust-reviews Federal Trade Commission v. St. Luke s Health System, Ltd. Complaint for Permanent Injunction, Case No. 1:13-CV BLW (D. Idaho Mar. 26, 2013) 8 Ibid 9 Federal Trade Commission. (2014). Statement of FTC Chairwoman Edith Ramirez on the U.S. District Court in the District of Idaho Ruling in the Matter of the Federal Trade Commission and the State of Idaho v. St. Luke s Health System Ltd. and Saltzer Medical Group, P.A. [Press release]. Retrieved from news-events/press-releases/2014/01/statement-ftc-chairwoman-edith-ramirez-us-district-court-district 10 Gibson Dunn Antitrust Merger Enforcement Update and Outlook. GibsonDunn.com (2014). aspx#_toc Saint Alphonsus Medical Center v. St. Luke s Health System, LTD.; Federal Trade Commission v. St. Luke s Health System, Ltd. Memorandum Decision and Order, Case No. 1:12-cv BLW (D. Idaho Jan. 1, 2014) Ibid 13 Ibid 14 Feinstein, Deborah L. (2014). Antitrust Enforcement in Health Care: Proscription, not Prescription. Washington, D.C.: Fifth National Accountable Care Organization Summit. documents/public_statements/409481/140619_aco_speech.pdf The information contained in this document is intended for general marketing purposes and information only. For terms and conditions of coverage, please refer to the specific policy wording. ACE Group /2015
How To Decide If An Aco Is A Merger Or A Non Merger
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com There Is Potential Federal Inconsistency Over ACOs
More informationHealth Care Mergers and Acquisitions
AMGA Annual Meeting March 24, 2015 Health Care Mergers and Acquisitions The Legal Perspective Presented by Joseph N. Wolfe, Esq. Hall, Render, Killian, Heath & Lyman, P.C. 1 Today s Agenda Introductory
More informationAmerican Health Lawyers Association and ABA Antitrust Section Antitrust in Healthcare Conference
American Health Lawyers Association and ABA Antitrust Section Antitrust in Healthcare Conference Antitrust and Healthcare Information Technology: Competing or Complementary Goals? Anthony W. Swisher Squire
More informationRecent Developments and Emerging Trends: Antitrust, Accountable Care Organizations, and Prompt Pay Litigation
Recent Developments and Emerging Trends: Antitrust, Accountable Care Organizations, and Prompt Pay Litigation William M. Katz, Jr. and William L. Banowsky Hospital Mergers More frequent since enactment
More informationDefining relevant market(s) product (parties overlapping products and close substitutes) and geographic (local, regional, national or global?
Overview of the Merger Review Process Scott P. Perlman Mayer Brown LLP The Conference Board Post Merger Integration Conference June 25, 2008 U.S. Merger Review Process Purpose of U.S. Federal Merger Review:
More informationLESSONS LEARNED FROM FTC INVESTIGATIONS AND CHALLENGES OF HEALTHCARE PROVIDER TRANSACTIONS
LESSONS LEARNED FROM FTC INVESTIGATIONS AND CHALLENGES OF HEALTHCARE PROVIDER TRANSACTIONS February 26, 2014 Gregory L. Baker, Pamela Jones Harbour, Jonathan L. Lewis, Lee H. Simowitz. Agenda Introductions
More informationHot Topics in Healthcare Management Liability
Hot Topics in Healthcare Management Liability Kim Delaney, RPLU Yo u r s o u r c e f o r p r o f e s s i o n a l l i a b i l i t y e d u c a t i o n a n d n e t w o r k i n g. Agenda Set the Stage Management
More informationGoing Vertical: The Hospital-Health Insurer Merger. By Christi J. Braun 1 Farrah Short
Going Vertical: The Hospital-Health Insurer Merger By Christi J. Braun 1 Farrah Short In today s health care reform environment, efficient health care delivery, stemming soaring health care costs, and
More informationDepartment of Justice
Department of Justice STATEMENT OF SHARIS A. POZEN CHIEF OF STAFF ANTITRUST DIVISION BEFORE THE SUBCOMMITTEE ON ANTITRUST, COMPETITION POLICY AND CONSUMER RIGHTS COMMITTEE ON THE JUDICIARY UNITED STATES
More informationPrivate Equity Newsletter
Private Equity Newsletter July 2006 What Every Investor Should Know Before Acquiring a Large Stake in a Public Company Private equity funds, hedge funds and other investors should consider a variety of
More informationDEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE Statement of JOEL I. KLEIN Assistant Attorney General Antitrust Division U.S. Department of Justice Before the House Committee on the Judiciary Concerning Consolidation in the Telecommunications
More informationNew Healthcare M&A Developments
2010 American Health Lawyers Association June 04, 2010 Vol. VIII Issue 22 New Healthcare M&A Developments By Michael W. Peregrine and Ashley M. Fischer, McDermott Will & Emery LLP Health lawyers advising
More informationCase 1:12-cv-00560-BLW-REB Document 100 Filed 04/05/13 Page 1 of 27
Case 1:12-cv-00560-BLW-REB Document 100 Filed 04/05/13 Page 1 of 27 J. Walter Sinclair, ISB #2243 Email: jwsinclair@stoel.com Sara M. Berry, ISB #7723 Email: smberry@stoel.com STOEL RIVES, LLP 101 S. Capitol
More informationPREPARED STATEMENT OF THE FEDERAL TRADE COMMISSION. Presented by David P. Wales Deputy Director Bureau of Competition Federal Trade Commission
PREPARED STATEMENT OF THE FEDERAL TRADE COMMISSION Presented by David P. Wales Deputy Director Bureau of Competition Federal Trade Commission before the COMMITTEE ON THE JUDICIARY UNITED STATES SENATE
More informationAntitrust Enforcement in Health Care: Proscription, not Prescription
Antitrust Enforcement in Health Care: Proscription, not Prescription Fifth National Accountable Care Organization Summit Washington, DC June 19, 2014 Deborah L. Feinstein, Director Bureau of Competition,
More informationALI-ABA Course of Study Corporate Mergers and Acquisitions. October 4-5, 2007 Boston, Massachusetts. Antitrust Issues in Mergers and Acquisitions
467 ALI-ABA Course of Study Corporate Mergers and Acquisitions October 4-5, 2007 Boston, Massachusetts Antitrust Issues in Mergers and Acquisitions By Hanno F. Kaiser Latham & Watkins LLP New York, New
More informationWhat Keeps You Up at Night?
What Keeps You Up at Night? A Series on Liability and Compliance Issues Addressing Enterprise Risk After the Affordable Care Act 37 Offices in 18 Countries Today s Host Peter A. Pavarini Squire Sanders
More informationCase 1:16-cv-01091 Document 1 Filed 06/10/16 Page 1 of 8
Case 1:16-cv-01091 Document 1 Filed 06/10/16 Page 1 of 8 UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA UNITED STATES OF AMERICA, Department of Justice Antitrust Division 450 5th Street, N.W.,
More informationPennsylvania Attorney General Challenge to Physician Group Consolidation: Lessons for the Future
NOVEMBER 2011 EXECUTIVE SUMMARY ANTITRUST PRACTICE GROUP Pennsylvania Attorney General Challenge to Physician Group Consolidation: Lessons for the Future Kristiana A. Garcia, Esquire Toby G. Singer, Esquire
More informationfor Private Purchasers Engaged in Value Purchasing of Health Care
Anti-Trust Guidelines for Private Purchasers Engaged in Value Purchasing of Health Care Issued by Buying Value BUYINGVALUE Purchasing Health Care That s Proven to Work Tim Muris and Bilal Sayyed of Kirkland
More information(Nov. 26, 2014), available at http://www.ftc.gov/news-events/press-releases/2014/11/ftc-puts-conditionspharmaceutical-joint-venture-between.
A Common Goal: The U.S. Federal Trade Commission s Healthcare Enforcement Program and Its Implications for ACOs Keynote Address Commissioner Julie Brill Sixth Annual Accountable Care Organization Summit
More informationThe Insurance Policy Enforcement Journal
This article was originally published in Enforce (Volume 11, Issue 1) The Insurance Policy Enforcement Journal Beyond Health Insurance: What Your Company Should be Doing Today to Protect Against New Risks
More informationMaster of Health Administration
Master of Health Administration THE IMPACT OF CLINICAL INTEGRATION ON JOINT MANAGED CARE CONTRACTING AMONG INDEPENDENT PHYSICIANS MARC MERTZ Executive Master of Health Administration Candidate, 2011 University
More informationAntitrust in the Digital Age: How Enduring Competition Principles Enforced by the Federal Trade Commission Apply to Today s Dynamic Marketplace
Antitrust in the Digital Age: How Enduring Competition Principles Enforced by the Federal Trade Commission Apply to Today s Dynamic Marketplace Prepared Statement of The Federal Trade Commission Before
More informationUNITED STATES OF AMERICA BEFORE FEDERAL TRADE COMMISSION. Jon Leibowitz, Chairman William E. Kovacic J. Thomas Rosch Edith Ramirez Julie Brill
UNITED STATES OF AMERICA BEFORE FEDERAL TRADE COMMISSION 0910081 COMMISSIONERS: Jon Leibowitz, Chairman William E. Kovacic J. Thomas Rosch Edith Ramirez Julie Brill ) In the Matter of ) ) Docket No. 9342
More informationMarket Definition Does Not Yield Evidence of Class-Wide Impact
Market Definition Does Not Yield Evidence of Class-Wide Impact Dr. Michael D. Noel, Ph.D. & Parker Normann, Ph.D. Edgeworth Economics June 2012 (published version available in the Antitrust Practitioner)
More informationUNITED STATES DISTRICT COURT EASTERN DISTRICT OF WISCONSIN. v. Case No. 14-mc-0052 DECISION AND ORDER
EEOC v. Union Pacific Railroad Company Doc. 13 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF WISCONSIN EQUAL EMPLOYMENT OPPORTUNITY COMMISSION, Petitioner, v. Case No. 14-mc-0052 UNION PACIFIC RAILROAD
More informationINTEGRATION STRATEGIES FOR A NEW HEALTH CARE ECONOMY
INTEGRATION STRATEGIES FOR A NEW HEALTH CARE ECONOMY Thomas William Baker Baker Donelson Bearman Caldwell & Berkowitz, P.C. Atlanta, Georgia (404) 221-6510 tbaker@bakerdonelson.com Prepared for East Georgia
More informationkaiser medicaid and the uninsured commission on September 2011
P O L I C Y B R I E F kaiser commission on medicaid and the uninsured September 2011 Explaining Douglas v. Independent Living Center: Questions about the Upcoming United States Supreme Court Case Regarding
More informationThe Changing Role of the Healthcare Risk Manager. December 2012. Sponsored by:
The Changing Role of the Healthcare Risk Manager December 2012 The Changing Role of the Healthcare Risk Manager The healthcare sector is undergoing broad and rapid transformation, driven by changing demographics,
More informationCPI Antitrust Chronicle May 2011 (1)
CPI Antitrust Chronicle May 2011 (1) ACOs And Antitrust Enforcement: Familiar Rules Raise New Concerns Jane E. Willis, Mark S. Popofsky & Daniel J. Bachner Ropes & Gray LLP www.competitionpolicyinternational.com
More informationThe Foreign Corrupt Practices Act: A 70s Revival?
Vol. III Issue Three June/July 2008 The Foreign Corrupt Practices Act: A 70s Revival? The Foreign Corrupt Practices Act (FCPA) a venerable statute from the 1970s is going through a 21 st Century revival,
More informationLegal FAQ: Introduction to Patent Litigation
Legal FAQ: Introduction to Patent Litigation by charlene m. morrow and dargaye churnet 1. Who enforces a patent? The U.S. Patent and Trademark Office grants a patent. Contrary to popular belief, a patent
More informationActing Together: State Attorneys General and the Rise of Multi-State Litigation. Thurbert Baker. Andrea Geddes. McKenna Long & Aldridge LLP
Acting Together: State Attorneys General and the Rise of Multi-State Litigation Thurbert Baker Andrea Geddes McKenna Long & Aldridge LLP 303 Peachtree Street, NE, Suite 5300 Atlanta, GA 30308-3265 (402)
More information0610166 UNITED STATES OF AMERICA BEFORE THE FEDERAL TRADE COMMISSION
0610166 UNITED STATES OF AMERICA BEFORE THE FEDERAL TRADE COMMISSION COMMISSIONERS: William E. Kovacic, Chairman Pamela Jones Harbour Jon Leibowitz J. Thomas Rosch ) In the Matter of ) ) Inova Health System
More informationProposed Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations Participating in the Medicare Shared Savings Program
Proposed Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations Participating in the Medicare Shared Savings Program I. Introduction The Patient Protection and Affordable Care
More informationEXPERT GUIDE Mergers & Acquisitions 2014. May 2014
EXPERT GUIDE Mergers & Acquisitions 2014 May 2014 Steven J. Daniels steven.daniels@skadden.com +1 302 651 3240 Faiz Ahmad faiz.ahmad@skadden.com +1 302 651 3045 Managing Sell-Side Financial Advisor Conflicts
More informationTHE ANATOMY OF BETTER INTELLIGENCE
HARNESS DATA Utilize comparative and actionable claims benchmarking data to capture the deeply rooted drivers of risk, errors and expense. LEVERAGE ANALYTICS Learn critical signals to discern the most
More informationOffice of Health Care Ombudsman, statutory duties
Office of Health Care Ombudsman, statutory duties Enabling statute, 8 V.S.A. 4089w (a) The department shall establish the office of the health care ombudsman by contract with any nonprofit organization.
More informationCase 3:14-cv-00137-AC Document 10 Filed 03/26/14 Page 1 of 14 Page ID#: 43
Case 3:14-cv-00137-AC Document 10 Filed 03/26/14 Page 1 of 14 Page ID#: 43 Calvin L. Keith, OSB No. 814368 CKeith@perkinscoie.com Sarah J. Crooks, OSB No. 971512 SCrooks@perkinscoie.com PERKINS COIE LLP
More informationEXHIBIT A Proposed Notice UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF MICHIGAN You have been identified as a member of a class which has been the subject of a settlement. This settlement may
More informationGroup Purchasing Organizations and Antitrust Law: Recent Developments. Mike Cowie, Esquire Dechert LLP Washington, DC
JANUARY 2011 MEMBER BRIEFING ANTITRUST PRACTICE GROUP Group Purchasing Organizations and Antitrust Law: Recent Developments Mike Cowie, Esquire Dechert LLP Washington, DC Throughout the United States,
More informationPatient Protection & Affordable Care Act Understanding Management Liability Exposures Created by the PPACA
Patient Protection & Affordable Care Act Understanding Management Liability Exposures Created by the PPACA May 7, 2015 Christopher Williams Travelers About PLUS PLUS is a nonprofit organization that provides
More informationTHE FAIR CREDIT REPORTING ACT RECENT (AND PENDING) DEVELOPMENTS. By Kevin G. Fitzgerald 1 FAIR AND ACCURATE CREDIT TRANSACTIONS ACT OF 2003
THE FAIR CREDIT REPORTING ACT RECENT (AND PENDING) DEVELOPMENTS By Kevin G. Fitzgerald 1 FAIR AND ACCURATE CREDIT TRANSACTIONS ACT OF 2003 Introduction On December 4, 2003, President Bush signed into law
More informationA Privacy and Data Security Checklist for All
July 2015 Many companies know they have to follow privacy and data security rules. Companies in the health care industry know about Health Insurance Portability and Accountability Act (HIPAA). Financial
More informationUNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION
UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION ) UNITED STATES OF AMERICA ) Department of Justice, Antitrust Division, ) 325 7th Street, N.W., Suite 300 ) Washington,
More informationCLIENT MEMORANDUM. I. The Basics. June 18, 2013
CLIENT MEMORANDUM FTC v. Actavis: Supreme Court Rejects Bright Line Tests for Reverse Payment Settlements; Complex Questions Remain in Structuring Pharmaceutical Patent Infringement Settlements June 18,
More informationManaging and Coordinating Non-Acute Care in an ACO Environment
Managing and Coordinating Non-Acute Care in an ACO Environment By Glen Roebuck, Vice President of Business Development, Health Dimensions Group Hospital and health care systems across the country are engaging
More informationBy Seth Gillston, with commentary from Tom Kim
M&A Risk Management: Collateral Liabilities and Solutions By Seth Gillston, with commentary from Tom Kim M&A Risk Management: Collateral Liabilities and Solutions Seth Gillston with commentary from Tom
More informationTESTIMONY OF ILLINOIS STATE REP. TERRY PARKE NATIONAL CONFERENCE OF INSURANCE LEGISLATORS (NCOIL) SUBCOMMITTEE ON OVERSIGHT AND INVESTIGATIONS
TESTIMONY OF ILLINOIS STATE REP. TERRY PARKE NATIONAL CONFERENCE OF INSURANCE LEGISLATORS (NCOIL) SUBCOMMITTEE ON OVERSIGHT AND INVESTIGATIONS COMMITTEE ON FINANCIAL SERVICES U.S. HOUSE OF REPRESENTATIVES
More informationRe: Proposed Statement of Antitrust Enforcement Policy Regarding ACOs Participating in the Medicare Shared Savings Program, Matter V100017
The Hon. Christine Varney Assistant Attorney General Antitrust Division U.S. Department of Justice 950 Pennsylvania Avenue, N.W. Washington, DC 20530 The Hon. Jon Leibowitz Chairman Federal Trade Commission
More informationTAXING BANKRUPTCY LIQUIDATION SALES. By Bruce A. Emard 1
TAXING BANKRUPTCY LIQUIDATION SALES I. Introduction By Bruce A. Emard 1 California taxes liquidation sales of tangible personal property (TPP) under its Sales and Use Tax Law (the Sales and Use Tax Law
More informationPUBLICATIONS, PRESENTATIONS & OTHER PROFESSIONAL ACTIVITIES
David Marx, Jr. David Marx, Jr. PUBLICATIONS, PRESENTATIONS & OTHER PROFESSIONAL ACTIVITIES PUBLICATIONS Books Antitrust and Healthcare: Meeting the Challenge, co-authored with James H. Sneed, published
More informationAccountable Care Organizations
Building a Healthy ACO Compliance Program HCCA 2014 Compliance Institute Mary C. Malone, Esq. Hancock, Daniel, Johnson & Nagle, P.C. Disclaimer: The content of this presentation does not constitute legal
More informationDEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE Statement of Christine A. Varney Assistant Attorney General Antitrust Division U.S. Department of Justice Before the Committee on the Judiciary United States Senate Hearing on Prohibiting
More informationManaging Risk at Bank of America Corporation. Overview
Managing Risk at Bank of America Corporation Overview Risk is inherent in every material business activity that we undertake. Our business exposes us to strategic, credit, market, liquidity, compliance,
More informationSTATEMENT J. BRUCE MCDONALD DEPUTY ASSISTANT ATTORNEY GENERAL ANTITRUST DIVISION BEFORE THE COMMITTEE ON THE JUDICIARY UNITED STATES SENATE CONCERNING
STATEMENT OF J. BRUCE MCDONALD DEPUTY ASSISTANT ATTORNEY GENERAL ANTITRUST DIVISION BEFORE THE COMMITTEE ON THE JUDICIARY UNITED STATES SENATE CONCERNING EXAMINING COMPETITION IN GROUP HEALTH CARE PRESENTED
More informationCPI Antitrust Journal October 2010 (1)
CPI Antitrust Journal October 2010 (1) Federal Courts and Enforcers Diagnose Physician Practice Associations with Risk of Conspiracy Liability: Degree of Integration is Crucial to Challenges to Medical
More informationPRIVATE COMPANY MANAGEMENT LIABILITY INSURANCE COVERAGE INCONSISTENCIES
PRIVATE COMPANY MANAGEMENT LIABILITY INSURANCE COVERAGE INCONSISTENCIES The private company management liability insurance industry continues to evolve. While the number of insurers participating in the
More informationSTATEMENT OF MATTHEW M. POLKA PRESIDENT AND CHIEF EXECUTIVE OFFICER AMERICAN CABLE ASSOCIATION
STATEMENT OF MATTHEW M. POLKA PRESIDENT AND CHIEF EXECUTIVE OFFICER AMERICAN CABLE ASSOCIATION BEFORE THE SUBCOMMITTEE ON REGULATORY REFORM, COMMERCIAL AND ANTITRUST LAW COMMITTEE ON THE JUDICIARY UNITED
More informationCooperation credit is a critical issue for
by Frank Sheeder, Esq., CCEP DOJ s pursuit of individual liability for corporate misconduct: The Yates Memo The DOJ has made it a priority to hold individuals accountable for organizational misdeeds both
More informationTHE LIABILITY IMPACTS OF HEALTHCARE REFORM. March 2014. Sponsored by:
THE LIABILITY IMPACTS OF HEALTHCARE REFORM March 2014 The Liability Impacts of Healthcare Reform An Advisen Special Report sponsored by OneBeacon Professional Insurance The Liability Impacts of Healthcare
More informationPreventive Treatment for the Provider s Back-office
Preventive Treatment for the Provider s Back-office A Closer Look at Administrative Simplification and the Key Strategies Healthcare Providers Can Take to Prepare By some estimates, nearly a third of every
More informationEmployee Relations. Howard S. Lavin and Elizabeth E. DiMichele
VOL. 34, NO. 4 SPRING 2009 Employee Relations L A W J O U R N A L Split Circuits Does Charging Party s Receipt of a Right-to-Sue Letter and Commencement of a Lawsuit Divest the EEOC of its Investigative
More information[J-119-2012] [MO: Saylor, J.] IN THE SUPREME COURT OF PENNSYLVANIA MIDDLE DISTRICT : : : : : : : : : : : : DISSENTING OPINION
[J-119-2012] [MO Saylor, J.] IN THE SUPREME COURT OF PENNSYLVANIA MIDDLE DISTRICT HERD CHIROPRACTIC CLINIC, P.C., v. Appellee STATE FARM MUTUAL AUTOMOBILE INSURANCE COMPANY, Appellant No. 35 MAP 2012 Appeal
More informationWHITEPAPER. Facts Association Executives Need to Know About Antitrust Law by Mark Alcorn
WHITEPAPER Facts Association Executives Need to Know About by Mark Alcorn Although many business owners and managers pay little or no attention to antitrust laws, these laws pose a substantial threat to
More informationCase 1:11-md-02290-RGS Document 396 Filed 12/06/13 Page 1 of 10 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ) ) ) ) ) )
Case 1:11-md-02290-RGS Document 396 Filed 12/06/13 Page 1 of 10 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS IN RE JPMORGAN CHASE MORTGAGE MODIFICATION LITIGATION THIS DOCUMENT RELATES TO: All
More informationIIROC s Regulatory Agenda: Market and Dealer Regulation
The Canadian Institute s 21 st Annual Securities Superconference Securities Regulation & Compliance Navigating New Rules across Canada and the U.S. IIROC s Regulatory Agenda: Market and Dealer Regulation
More informationCase 3:10-cv-00571-WDS-DGW Document 62 Filed 08/26/13 Page 1 of 10 Page ID #210
Case 3:10-cv-00571-WDS-DGW Document 62 Filed 08/26/13 Page 1 of 10 Page ID #210 IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF ILLINOIS PAMELA GRONEMEYER, ) ) Plaintiff, ) ) v. ) No.
More informationII. SHARED SAVINGS PROGRAM AND COST-REDUCTION INCENTIVES
E-ALERT Health Care April 15, 2011 ACCOUNTABLE CARE ORGANIZATION BASICS The Affordable Care Act establishes the Medicare Shared Savings Program ( Program ), which provides for the development of accountable
More informationPATIENT PROTECTION AND AFFORDABLE CARE ACT. Status of Federal and State Efforts to Establish Health Insurance Exchanges for Small Businesses
United States Government Accountability Office Report to the Chairman, Committee on Small Business, House of Representatives June 2013 PATIENT PROTECTION AND AFFORDABLE CARE ACT Status of Federal and State
More information340B Omnibus Guidance Would Significantly Narrow the Pool of Eligible Patients
White Paper August 31, 2015 340B Omnibus Guidance Would Significantly Narrow the Pool of Eligible Patients By Kristi V. Kung This client alert also was published as a bylined article on Law360 on September
More informationThe Most Commonly Asked Questions
www.bankdirector.com Strong Board. Strong Bank. Bank Director s Educational Program for Members of the Board D & O LIABILITY INSURANCE: The Most Commonly Asked Questions WHITE PAPER 2 D & O LIABILITY INSURANCE:
More informationCOMMONWEALTH OF MASSACHUSETTS OF THE TRIAL COURT CIVIL ACTION NO. 07-1083-C
COMMONWEALTH OF MASSACHUSETTS WORCESTER, SS. SUPERIOR COURT DEPARTMENT OF THE TRIAL COURT CIVIL ACTION NO. 07-1083-C ) PHILIPPE E. GUT AND GWEN PRATT GUT, ) on behalf of themselves and all ) others similarly
More informationProtecting Your Clients Healthcare Licenses in Several States After a Medical Malpractice Case:
Protecting Your Clients Healthcare Licenses in Several States After a Medical Malpractice Case: Your Failure to Watch Out for Their Licenses Could Cost You Yours Michael V. Favia Quintarios, Prieto, Wood
More informationAdditional Information About Accountable Care Organizations
Additional Information About Accountable Care Organizations For more information, please contact: April 2011 On March 31st, the federal government outlined proposed actions relating to Accountable Care
More informationInternational Trade and Government Regulation practice in the Washington, DC office of Dechert LLP.
FCPA Enforcement: 2015 Highlights and Trends By: Jeremy Zucker, Darshak Dholakia, and Hrishikesh Hari 1 With record settlements, continued aggressive enforcement, a renewed focus on prosecuting individuals,
More informationThe Next Chapter in Antitrust and Health Care: Health Insurance Mergers An ABA Program Summary
The Next Chapter in Antitrust and Health Care: Health Insurance Mergers An ABA Program Summary By Larissa C. Bergin 1 Jones Day As health insurance companies prepare for implementation of the Patient Protection
More informationWHITE PAPER The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain
WHITE PAPER The Impact of Rising Generic Drug Prices on the U.S. Drug Supply Chain Over the past two years, the pharmacy industry has seen unprecedented increases in the prices of generic drugs, causing
More informationSTATE. of the MARKET
STATE of the MARKET TABLE OF CONTENTS The Takeaway 1 The Overview 2 Review & Outlook 3 Placement Considerations 6 Brands 9 THE TAKEAWAY Healthcare in the United States is changing dramatically, as facilities
More informationNo. 3 09 0033 THIRD DISTRICT A.D., 2009
No. 3 09 0033 Filed December 16, 2009 IN THE APPELLATE COURT OF ILLINOIS THIRD DISTRICT A.D., 2009 KEPPLE AND COMPANY, INC., ) Appeal from the Circuit Court an Illinois Corporation, ) of the 10th Judicial
More informationA New Headache For Employers: Whistleblower Claims Under the Affordable Care Act
March 2013 A New Headache For Employers: Whistleblower Claims Under the Affordable Care Act BY STEPHEN H. HARRIS, MELINDA A. GORDON & MARC E. BERNSTEIN INTRODUCTION On February 22, 2013, the United States
More informationThe trademark lawyer as brand manager
The trademark lawyer as brand manager This text first appeared in the IAM magazine supplement Brands in the Boardroom 2005 May 2005 For further information please visit www.iam-magazine.com Feature The
More informationHow To Choose The Right Form Of Joint Venture
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com How To Choose The Right Form Of Joint Venture Law360,
More informationCMS proposed rule on ACOs: http://www.gpo.gov/fdsys/pkg/fr-2011-04-07/pdf/2011-7880.pdf
April 7, 2011 Dear Physician Colleague: On March 31, 2011, the Centers for Medicare & Medicaid Services (CMS) issued its long awaited proposed regulations on the Medicare Shared Savings/Accountable Care
More informationState Exchange Planning and Establishment Grants
October 4, 2010 The Honorable Kathleen Sebelius Secretary, U.S. Department of Health and Human Services 200 Independence Avenue, S.W. Washington, DC 20201 Mr. Jay Angoff Director, Office of Consumer Information
More informationTHE STATE OF FLORIDA
THE STATE OF FLORIDA OFFICE OF INSURANCE REGULATION MARKET INVESTIGATIONS TARGET MARKET CONDUCT FINAL EXAMINATION REPORT OF THE FLORIDA COMPREHENSIVE HEALTH ASSOCIATION AS OF APRIL 1, 2013 FLORIDA COMPANY
More informationInsurance Antitrust. Strike Three: Antitrust Claims in Florida Auto Insurer Proceeding Dismissed With Prejudice. This is an advertisement.
Strike Three: Antitrust Claims in Florida Auto Insurer Proceeding Dismissed With Prejudice On September 23, District Court Judge Gregory Presnell (Middle District of Florida) dismissed the antitrust claims
More informationHot Buttons in Health Care Antitrust
Hot Buttons in Health Care Antitrust Arthur Lerner Crowell & Moring LLP Payors, Plans and Managed Care Law Institute American Health Lawyers Association Chicago, Illinois December 6-7, 2011 2011 Hot Spots
More informationSupreme Court Decision Affirming Judicial Right to Review EEOC Actions
Supreme Court Decision Affirming Judicial Right to Review EEOC Actions The Supreme Court Holds That EEOC s Conciliation Efforts Are Subject to Judicial Review, Albeit Narrow SUMMARY A unanimous Supreme
More informationCredit Rating Agencies
Capital Markets Credit Rating Agencies The Dodd-Frank Act includes reforms that address credit rating agencies and the credit ratings they provide. The Act seeks to impose corporate governance guidelines,
More informationCase: 1:12-cv-10064 Document #: 137 Filed: 07/29/14 Page 1 of 11 PageID #:1365
Case: 1:12-cv-10064 Document #: 137 Filed: 07/29/14 Page 1 of 11 PageID #:1365 IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION IN RE CAPITAL ONE TELEPHONE CONSUMER
More informationFact Sheet. Prescription Data Mining
November 19, 2008 Fact Sheet Prescription Data Mining The Prescription Project promotes evidence-based prescribing and works to eliminate conflicts of interest in medicine due to pharmaceutical marketing
More informationCROSSROADS HOSPICE HIPAA PRIVACY NOTICE
CROSSROADS HOSPICE HIPAA PRIVACY NOTICE THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN OBTAIN ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY 1.
More informationIfrah Law Internet Advertising Practice
IfrahLaw Hands-on Counsel, Gloves-off Litigation Ifrah Law Internet Advertising Practice About Ifrah Law Ifrah Law, headquartered a block from the White House in Washington, D.C., is a leading provider
More informationIU Health Quality Partners
FREQUENTLY ASKED QUESTIONS 1) What is IU Health Quality Partners? It is a clinically integrated provider group; it is not a contracted health insurance plan network where physicians receive a set fee for
More informationCyber Insurance in an Evolving Liability Landscape: Informed, Strategic Expectations Monday, February 29, 2016 2:00pm 3:00pm
Cyber Insurance in an Evolving Liability Landscape: Informed, Strategic Expectations Monday, February 29, 2016 2:00pm 3:00pm Kimberly B. Holmes, Esq., RPLU VP, Product Development, Chief Underwriting Office
More informationThe Cornerstones of Accountable Care ACO
The Cornerstones of Accountable Care Clinical Integration Care Coordination ACO Information Technology Financial Management The Accountable Care Organization is emerging as an important care delivery and
More informationIN THE APPELLATE COURT OF ILLINOIS FIRST DISTRICT
2016 IL App (1st) 150810-U Nos. 1-15-0810, 1-15-0942 cons. Fourth Division June 30, 2016 NOTICE: This order was filed under Supreme Court Rule 23 and may not be cited as precedent by any party except in
More informationFEDERAL TRADE COMMISSION / DEPARTMENT OF JUSTICE
FEDERAL TRADE COMMISSION / DEPARTMENT OF JUSTICE Federal Trade Commission ( FTC ) Antitrust Division of the Department of Justice ( DOJ ) Statement of Antitrust Enforcement Policy Regarding Accountable
More information